Regeneron PharmaceuticalsREGN 
$1,162.002.04%24h
2.04%24h
Global rank111
Market cap$124.48B
Change 7d2.20%
YTD Performance32.97%
SP500 benchmarkOutperform
P/E0
P/S9.49
Revenue$13.12B
Earnings$3.95B
Dividend yield-
Main Sector
Healthcare
Regeneron Pharmaceuticals REGN Total Debt
REGN Total Debt in 2022: $2.70B
According to Regeneron Pharmaceuticals latest financial reports the total debt is $2.70B, an increase of 0.06% to 2022. At the end of 2022 company had $2.70B total debt. This figure represents the debts and financial obligations that Regeneron Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Regeneron Pharmaceuticals REGN Total Debt History from 2023 to 2022
-
Value:-
REGN Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $2.70B | 0.06% |
| 2022 | $2.70B | 36.43% |
| 2021 | $1.98B | -26.55% |
| 2020 | $2.70B | 277.60% |
| 2019 | $713.90M | 0.76% |
| 2018 | $708.50M | - |
View the Top Total Debt Stocks 
